Stay updated on Daratumumab Combo With or Without Venetoclax in MM Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo With or Without Venetoclax in MM Clinical Trial page.

Latest updates to the Daratumumab Combo With or Without Venetoclax in MM Clinical Trial page
- Check5 days agoChange DetectedThe page now shows a consolidated Locations section with study sites in Indiana, Minnesota, and Wisconsin. The revision also updates the page version to v3.3.3 and removes the separate Indiana Locations, Minnesota Locations, and Wisconsin Locations entries from the previous revision.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page header. No substantive content changes to the study details, eligibility criteria, or results sections.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page no longer shows the government funding operating status notice, which previously warned that information may not be up to date and directed users to cc.nih.gov and opm.gov. This change does not affect any study details, eligibility criteria, or results.SummaryDifference0.3%

- Check62 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots; the study details page appears unchanged.SummaryDifference0.3%

- Check84 days agoChange DetectedUpdated operating-status notice and bumped version from v3.1.0 to v3.2.0; substantive changes center on current status and versioning, replacing the prior version reference.SummaryDifference2%

- Check91 days agoChange DetectedPage updated to version v3.1.0; removed the plasma cell myeloma resource and added the new revision tag, indicating an update but not introducing new core content.SummaryDifference0.2%

Stay in the know with updates to Daratumumab Combo With or Without Venetoclax in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo With or Without Venetoclax in MM Clinical Trial page.